Search

everythinglearnresearchcommunity

for

Search:↓

An 11-year-old female Pinscher with Pemphigus Foliaceus was successfully diagnosed and treated.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

A woman had an allergic skin reaction to a hair loss treatment containing minoxidil and should not use it.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Vitamin B supplements may reverse grey hair.

The document explains various skin conditions and their treatments.

Dermatological conditions are complex and treatments often have mixed results.

A woman lost her hair after taking acyclovir, but it grew back when she stopped the medication.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Alopecia areata treatment varies, with no optimal method established yet.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

A systematic approach is crucial for managing hair loss in women.